Related Experiment Video
Updated: Jun 25, 2026
07:54
Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
17.1K
Measuring cancer driving force of chromosomal aberrations through multi-layer Boolean implication networks.
Ilaria Cosentini1, Daniele Filippo Condorelli2, Giorgio Locicero1
1Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), Palermo, Italy.
Plos One
|April 9, 2024
Summary
This study introduces COMBO, a method using multi-omics data to link chromosomal aberrations to cancer drivers. COMBO identifies chromosomal gain in chromosome 20 as a significant cancer driver across multiple cancer types.
Area of Science:
- Computational Biology
- Genomics
- Cancer Research
Background:
- Multi-layer complex networks are vital for analyzing biological systems.
- Chromosomal aberrations are implicated in cancer development.
- Integrating multi-omics data offers deeper insights into cancer biology.
Purpose of the Study:
- To present COMBO (Combining Multi Bio Omics) for analyzing multi-layer biological networks.
- To investigate the role of chromosomal aberrations as cancer drivers.
- To identify relationships between transcriptome and epigenome using gene expression and DNA methylation data.
Main Methods:
- Developed COMBO to integrate gene expression and DNA methylation data.
- Constructed heterogeneous multi-layer networks.
- Analyzed TCGA cancer datasets (COAD, BLCA, BRCA, CESC, STAD).
- Focused on chromosomal numerical aberrations, specifically gain in chromosome 20 and 8q amplification.
Main Results:
- COMBO successfully identified complex relationships between transcriptome and epigenome.
- The method demonstrated the cancer driver role of chromosome 20 amplification in various cancer histotypes.
- Chromosome 8q amplification was also analyzed within the TCGA datasets.
Conclusions:
- COMBO is advantageous for integrating multi-omics data to uncover novel biological insights.
- Chromosomal aberrations, such as chromosome 20 gain, can act as significant cancer drivers.
- The findings highlight the utility of COMBO in cancer driver identification using multi-omics data.
More Related Videos
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...